Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TANK antisense RNA 1 (TANK-AS1) is a long noncoding RNA (lncRNA) that is transcribed in the antisense direction relative to the TANK gene locus. Antisense lncRNAs like TANK-AS1 play a role in regulating the expression of overlapping or neighboring protein-coding genes through a variety of cis- and trans-acting regulatory mechanisms, including modulation of chromatin structure, recruitment of epigenetic modifiers, formation of RNA:RNA duplexes, and transcriptional interference. These RNAs are part of a broad class called natural antisense transcripts (NATs), which are pervasive in the human genome and contribute to the fine-tuning of gene expression, with emerging roles in development, cancer, and potentially other diseases[1][2][3]. There is currently insufficient evidence to classify TANK-AS1 as a direct therapeutic target (such as a receptor, enzyme, or ion channel), nor are any clinically approved drugs known to act directly on it.
Transcriptional interference; RNA:RNA hybrid formation; Induction of promoter methylation; Recruitment of chromatin/histone-modifying complexes; Regulation of RNA stability
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TANK antisense RNA 1 (TANK-AS1).